Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
In a recent randomized, multicenter trial, the use of a microaxial flow pump in addition to standard care resulted in a mortality reduction at 180 days among STEMI patients with cardiogenic shock, with a significant hazard ratio of 0.74.
Cardiology April 19th 2024
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH